Tamara A. Favorito Acquires Shares in Zevra Therapeutics, Inc.

On September 12, 2025, Tamara A. Favorito, a director of Zevra Therapeutics, Inc., acquired 3,175 shares of the company's common stock at a price of $7.7852 per share. Following this transaction, Favorito owns a total of 3,894 shares directly. This acquisition is reported under Form 4, which is used for reporting changes in ownership of company insiders. The transaction highlights Favorito's continued investment in the company, reflecting confidence in its future prospects.